Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mumps”

112 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 112 results

Post-approval studies (Phase 4)Study completedNCT03183765
What this trial is testing

Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts

Who this might be right for
Common WartPlantar Wart
Assiut University 48
Large-scale testing (Phase 3)Study completedNCT02058563
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Who this might be right for
RubellaMumpsMeasles
GlaxoSmithKline 996
Not applicableWithdrawnNCT01738841
What this trial is testing

Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

Who this might be right for
MumpsRubellaMeasles+1 more
GlaxoSmithKline
Post-approval studies (Phase 4)UnknownNCT01770119
What this trial is testing

Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients

Who this might be right for
Measles
Klara M. Pósfay Barbe 90
Large-scale testing (Phase 3)Study completedNCT05065177
What this trial is testing

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Who this might be right for
Mumps
Sinovac Research and Development Co., Ltd. 1,140
Post-approval studies (Phase 4)Study completedNCT03160820
What this trial is testing

Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine

Who this might be right for
MeaslesMumpsRubella+1 more
Centers for Disease Control and Prevention, China 873
Testing effectiveness (Phase 2)Study completedNCT05630846
What this trial is testing

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Who this might be right for
Measles; Mumps; Rubella; ChickenpoxMeasles
GlaxoSmithKline 801
Large-scale testing (Phase 3)Study completedNCT01702428
What this trial is testing

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

Who this might be right for
RubellaMeaslesMumps
GlaxoSmithKline 5,016
Large-scale testing (Phase 3)UnknownNCT05894395
What this trial is testing

Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination

Who this might be right for
MumpsMeaslesRubella
University of Zurich 200
Large-scale testing (Phase 3)Study completedNCT00985166
What this trial is testing

ProQuad in Healthy 4 to 6 Year Old Children (V221-014)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 801
Large-scale testing (Phase 3)Study completedNCT00432042
What this trial is testing

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Who this might be right for
VaricellaMeaslesMumps+7 more
Merck Sharp & Dohme LLC 955
Testing effectiveness (Phase 2)Study completedNCT00892775
What this trial is testing

Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds

Who this might be right for
MeaslesVaricellaMumps+1 more
GlaxoSmithKline 501
Large-scale testing (Phase 3)Study completedNCT00626327
What this trial is testing

Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers

Who this might be right for
Meningococcal Infections
Novartis Vaccines 1,630
Post-approval studies (Phase 4)Study completedNCT00126997
What this trial is testing

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Who this might be right for
MumpsRubellaMeasles+1 more
GlaxoSmithKline 1,439
Not applicableNot Yet RecruitingNCT07338851
What this trial is testing

The Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

Who this might be right for
PolioMeaslesRubella+2 more
China National Biotec Group Company Limited 600
Post-approval studies (Phase 4)Study completedNCT03780179
What this trial is testing

MMR at 6 Months Trial

Who this might be right for
Meales-mumps-rubella Vaccine
Rigshospitalet, Denmark 6,540
Not applicableUnknownNCT02712203
What this trial is testing

MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.

Who this might be right for
Measles
CHU de Quebec-Universite Laval 5,808
Not applicableStudy completedNCT01369394
What this trial is testing

Making Decisions About the Measles-Mumps-Rubella Vaccine

Who this might be right for
MeaslesMumpsRubella+1 more
University of Michigan 79
Large-scale testing (Phase 3)Study completedNCT06399003
What this trial is testing

Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months

Who this might be right for
Measles-Mumps-Rubella
Shanghai Institute Of Biological Products 1,200
Large-scale testing (Phase 3)Study completedNCT00406211
What this trial is testing

Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

Who this might be right for
RubellaVaricellaMumps+1 more
GlaxoSmithKline 398
Load More Results